chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 90.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Fall, Haemodialysis, Haemorrhage, Life support, Multi-organ failure
Clinical narrative: Initial report was received on 1 November 2011 from a consumer who is also the patient's daughter. A 90 year-old female patient with a history of MI's (myocardial infarctions) had received FLUZONE HIGH-DOSE (lot number, route and site of administration not reported) on 09 September 2011 and at 4 AM the next day 10 September 2011, experienced "symptoms" of a heart attack that caused her to fall, tongue swelling and hoarseness inhibiting her capability to speak and swallow. EMT's (emergency medical technicians) treated the patient based on her PMH (past medical history) of heart attacks and symptomology. She was transported to the ED (emergency department). The ER (emergency room) physician informed the patient's daughter that the patient had been treated for a heart attack but "there is something else going on but we don't know what it is". The patient was hospitalized. According to the reporter, throughout hospitalization the patient developed internal bleeding, ARF (acute renal failure resulting in hemodialysis, respiratory and heart failure. The patient was placed on total life support and died on 27 September 2011. No autopsy was conducted per the family. The medical examiner reported the cause of death to be multisystem organ failure, sepsis and aspiration pneumonia. According to the reporter, she feels her mother experienced a "serious reaction" to the flu vaccine and it was "probably what had killed her." No further information was available at the time of the report. Outcome was fatal. Documents held by sender: none.
Age: 90.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Pneumonia aspiration, Renal failure acute, Respiratory failure, Sepsis, Speech disorder
Clinical narrative: Initial report was received on 1 November 2011 from a consumer who is also the patient's daughter. A 90 year-old female patient with a history of MI's (myocardial infarctions) had received FLUZONE HIGH-DOSE (lot number, route and site of administration not reported) on 09 September 2011 and at 4 AM the next day 10 September 2011, experienced "symptoms" of a heart attack that caused her to fall, tongue swelling and hoarseness inhibiting her capability to speak and swallow. EMT's (emergency medical technicians) treated the patient based on her PMH (past medical history) of heart attacks and symptomology. She was transported to the ED (emergency department). The ER (emergency room) physician informed the patient's daughter that the patient had been treated for a heart attack but "there is something else going on but we don't know what it is". The patient was hospitalized. According to the reporter, throughout hospitalization the patient developed internal bleeding, ARF (acute renal failure resulting in hemodialysis, respiratory and heart failure. The patient was placed on total life support and died on 27 September 2011. No autopsy was conducted per the family. The medical examiner reported the cause of death to be multisystem organ failure, sepsis and aspiration pneumonia. According to the reporter, she feels her mother experienced a "serious reaction" to the flu vaccine and it was "probably what had killed her." No further information was available at the time of the report. Outcome was fatal. Documents held by sender: none.
Age: 90.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Swollen tongue
Clinical narrative: Initial report was received on 1 November 2011 from a consumer who is also the patient's daughter. A 90 year-old female patient with a history of MI's (myocardial infarctions) had received FLUZONE HIGH-DOSE (lot number, route and site of administration not reported) on 09 September 2011 and at 4 AM the next day 10 September 2011, experienced "symptoms" of a heart attack that caused her to fall, tongue swelling and hoarseness inhibiting her capability to speak and swallow. EMT's (emergency medical technicians) treated the patient based on her PMH (past medical history) of heart attacks and symptomology. She was transported to the ED (emergency department). The ER (emergency room) physician informed the patient's daughter that the patient had been treated for a heart attack but "there is something else going on but we don't know what it is". The patient was hospitalized. According to the reporter, throughout hospitalization the patient developed internal bleeding, ARF (acute renal failure resulting in hemodialysis, respiratory and heart failure. The patient was placed on total life support and died on 27 September 2011. No autopsy was conducted per the family. The medical examiner reported the cause of death to be multisystem organ failure, sepsis and aspiration pneumonia. According to the reporter, she feels her mother experienced a "serious reaction" to the flu vaccine and it was "probably what had killed her." No further information was available at the time of the report. Outcome was fatal. Documents held by sender: none.
Age: 64.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Antinuclear antibody negative, C-reactive protein increased, Parvovirus B19 test positive, Polyarthritis, Rheumatoid factor negative
Clinical narrative: 4 days following TDAP booster, developed polyarthritis - hands, wrists, elbows. Diminished, but partially prevalent symptoms after 3 months.
Age: 64.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Arthralgia, Blood test normal, Joint stiffness, Liver function test normal, Musculoskeletal pain
Clinical narrative: 4 days following TDAP booster, developed polyarthritis - hands, wrists, elbows. Diminished, but partially prevalent symptoms after 3 months.
Age: 64.0
Sex: F
Vaccine: TDAP, TDAP
Symptoms: Oedema peripheral, Pain in extremity, Parvovirus B19 test negative, Rheumatoid factor negative, Vaccination complication
Clinical narrative: 4 days following TDAP booster, developed polyarthritis - hands, wrists, elbows. Diminished, but partially prevalent symptoms after 3 months.
Age: 3.0
Sex: M
Vaccine: FLUN3
Symptoms: Hypersensitivity, Rash
Clinical narrative: Allergic reaction, rash.
Age: 27.0
Sex: F
Vaccine: HEPAB, TYP
Symptoms: Discomfort, Fatigue, Pyrexia
Clinical narrative: Patient became fatigued and uncomfortable, developed fever to 102.5 F. Treated with IVF and oral acetaminophen to good effect.
Age: 60.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Hypersensitivity, Pharyngeal oedema, Pruritus, Rash papular
Clinical narrative: Pt started itching and had little red raised bumps.  Began to feel a swelling in the throat.  Called her physician and was advised to take an antihistamine and Pepcid twice a day for 5 days.  11/8 had very little change.  Went to Dermatologist and was told it was an allergic reaction.  Was given a cortisone injection.  Was told it might 24 to 48 hours to see improvement.  11/9 Still very little improvement.  11/11 Throat no longer felt swollen and itching was less.
Age: 60.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Pharyngeal oedema, Rash erythematous, Rash generalised, Rash pruritic
Clinical narrative: Pt started itching and had little red raised bumps.  Began to feel a swelling in the throat.  Called her physician and was advised to take an antihistamine and Pepcid twice a day for 5 days.  11/8 had very little change.  Went to Dermatologist and was told it was an allergic reaction.  Was given a cortisone injection.  Was told it might 24 to 48 hours to see improvement.  11/9 Still very little improvement.  11/11 Throat no longer felt swollen and itching was less.
Age: 60.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Hypersensitivity, Pharyngeal oedema, Pruritus, Rash papular
Clinical narrative: Initial report received from a consumer on 09 November 2011. A 60-year-old female patient received an intramuscular left deltoid injection of FLUZONE, sanofi pasteur Inc. lot number UH467AA, on 03 November 2011 at 9:30 AM. The patient had no known drug allergy. She refused to provide concomitant medications. The patient had no illnesses at the time of vaccination, had no other vaccines within 4 weeks of the FLUZONE and had no adverse events following prior vaccinations. On 03 November 2011 at 8:00 PM, the patient developed throat swelling, rash which was wide spread over her body from her neck down to her mid thigh and described as red, raised, itchy and tiny red bumps. The patient's laboratory testing was reported as unknown. The patient required a doctor visit. The outcome was reported as not recovered. Documents held by sender: None.
Age: 60.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Pharyngeal oedema, Rash erythematous, Rash generalised, Rash pruritic
Clinical narrative: Initial report received from a consumer on 09 November 2011. A 60-year-old female patient received an intramuscular left deltoid injection of FLUZONE, sanofi pasteur Inc. lot number UH467AA, on 03 November 2011 at 9:30 AM. The patient had no known drug allergy. She refused to provide concomitant medications. The patient had no illnesses at the time of vaccination, had no other vaccines within 4 weeks of the FLUZONE and had no adverse events following prior vaccinations. On 03 November 2011 at 8:00 PM, the patient developed throat swelling, rash which was wide spread over her body from her neck down to her mid thigh and described as red, raised, itchy and tiny red bumps. The patient's laboratory testing was reported as unknown. The patient required a doctor visit. The outcome was reported as not recovered. Documents held by sender: None.
Age: 5.0
Sex: F
Vaccine: DTAP, HEP, IPV, MMR
Symptoms: Body temperature increased, Convulsion, Crying, Pallor, Skin discolouration
Clinical narrative: Pt received vaccination at facility 11/15/11 at 9:30AM. Mother reported one seizure in 2009. Clinician was contacted at previous visit and stated no connections to vaccination. Mother reports no adverse rxn after previous vaccination. School nurse calls 11/16/11 to report that student had febrile seizure at 11:15AM. Pt. temp was 98 degrees F - 102 degrees F within 30 min. Ambulance was called and pt. taken to hospital. Nurse states that pt. was found at lunch pale, dusky color. Returned at nurse office. Seizing & whimpering x30 min.
Age: 31.0
Sex: M
Vaccine: DTAPIPV, HEPAB, MNQ
Symptoms: No adverse event
Clinical narrative: No adverse events noted.
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Injection site swelling, Pain, Swelling
Clinical narrative: Day after flu shot - major swelling to (R) arm (R) breast. (R) armpit with lymph nodes, major pain, (R) shoulder swelling and pain.
Age: 0.6
Sex: U
Vaccine: DTAPIPVHIB, FLU3, HEP, PNC13
Symptoms: Blood culture, CSF culture, Dyskinesia, Full blood count, Lumbar puncture
Clinical narrative: Parents observed jerky movements and child was taken to the ER. This was the day after vaccination. Also had a fever, low grade.
Age: 0.6
Sex: U
Vaccine: DTAPIPVHIB, FLU3, HEP, PNC13
Symptoms: Pyrexia
Clinical narrative: Parents observed jerky movements and child was taken to the ER. This was the day after vaccination. Also had a fever, low grade.
Age: 11.0
Sex: F
Vaccine: VARCEL
Symptoms: Death, Diarrhoea, Escherichia infection
Clinical narrative: Diarrheal illness on 10/28/11 - transferred to hospital  on 10/31/11. Died on 11/2/11 - dx with E-coli 0157 Huhs. She was Trisomy 21 (Downs) & epilepsy, well controlled with med.
Sex: F
Vaccine: TDAP
Symptoms: Bordetella test, Bordetella test positive, Pertussis, Sputum normal
Clinical narrative: Initial report received from a health care professional on 07 November 2011. This reporter also reported other adverse events which were captured in case number 2011-10824 and 2011-10825. A female patient (age not reported) received an injection (route and site not reported) of ADACEL, sanofi pasteur lot not reported, on 28 August 2007. The patient had no other vaccinations within 4 weeks of the ADACEL. The patient's medical history and concomitant medications were not reported. On 11 October 2011, the patient was diagnosed with pertussis. The patient's blood work for IgG and IgM were positive for pertussis. The patient's sputum smear on 11 October 2011 showed routine respiratory flora. The outcome was not reported. Documents held by sender: None.
Sex: F
Vaccine: TDAP
Symptoms: Bordetella test, Bordetella test positive, Cough, Pertussis, Respiratory tract congestion
Clinical narrative: Initial report received from a health care professional on 07 November 2011. This reporter also reported other adverse events which were captured in case number 2011-10823 and 2011-10825. A female patient (age not reported) received dose 1 injection (route and site not reported) of ADACEL, sanofi pasteur lot not reported, on 03 August 2006. The patient had no other vaccinations within 4 weeks of the ADACEL. The patient's medical history and concomitant medications were not reported. On 28 October 2011, the patient experienced severe cough, nasal drainage and congestion which persisted. She was diagnosed with pertussis. The patient's blood work for IgG and IgM were positive for pertussis. The outcome was not reported. Documents held by sender: None.
Sex: F
Vaccine: TDAP
Symptoms: Rhinorrhoea
Clinical narrative: Initial report received from a health care professional on 07 November 2011. This reporter also reported other adverse events which were captured in case number 2011-10823 and 2011-10825. A female patient (age not reported) received dose 1 injection (route and site not reported) of ADACEL, sanofi pasteur lot not reported, on 03 August 2006. The patient had no other vaccinations within 4 weeks of the ADACEL. The patient's medical history and concomitant medications were not reported. On 28 October 2011, the patient experienced severe cough, nasal drainage and congestion which persisted. She was diagnosed with pertussis. The patient's blood work for IgG and IgM were positive for pertussis. The outcome was not reported. Documents held by sender: None.
Sex: F
Vaccine: TDAP
Symptoms: Cough, Respiratory tract congestion, Rhinorrhoea
Clinical narrative: Initial report received from a health care professional on 07 November 2011. This reporter also reported other adverse events which were captured in case number 2011-10823 and 2011-10824. A female patient (age not reported) received dose 1 injection (route and site not reported) of ADACEL, sanofi pasteur Ltd. lot number C2456AA, on 22 May 2006. The patient had no other vaccinations within 4 weeks of the ADACEL. The patient's medical history and concomitant medications were not reported. On 28 October 2011, the patient experienced severe cough, nasal drainage and congestion. The patient was not tested for pertussis. Two other staff members tested positive for IgG and IgM and are captured in cases 2011-10823 and 2011-10824. The outcome was not reported. Two other staff members tested positive for IgG and IgM and are captured in cases 2011-10823 and 2011-10824. Documents held by sender: None.
Sex: U
Vaccine: TDAP, TYP
Symptoms: Dysphagia
Clinical narrative: Initial report was received on 07 November 2011 from a health care professional. A patient (name, gender and date of birth not reported) had received ADACEL (lot number, route, site and date of administration not reported) and TYPHIM VI  (lot number, route, site and date of administration not reported) and an unspecified amount of time after vaccination, experienced difficulty swallowing. No further information was available at the time of the report. The patient's outcome was not reported. The reporter for this case is the same as for case 2011-10829. Documents held by sender: none.
Age: 54.0
Sex: F
Vaccine: TDAP
Symptoms: Asthenia, Condition aggravated, Fatigue, Heart rate increased, Supraventricular tachycardia
Clinical narrative: Initial report received from a consumer on 08 November 2011. A female patient received an injection (route and site not reported) of ADACEL, sanofi pasteur Ltd. lot number not reported, on 27 October 2011. The patient's medical history includes supraventricular tachycardia (SVT) with a rapid heart rate for which she takes atenolol. She had no illness at the time of vaccination and had no other medications within 4 weeks of the ADACEL. The patient received the ADACEL as part of treatment for a cut on the leg at an Emergency Room. Since receiving the ADACEL, the patient has been having increased episodes of SVT and increased rapid heart rate. The patient was tired and had no energy. The patient stated that she has a cardiologist but has not seen him yet. The outcome was reported as not recovered. Documents held by sender: None.
Age: 45.0
Sex: M
Vaccine: FLU3
Symptoms: Dyspnoea, Lacrimation increased, Palpitations, Swollen tongue
Clinical narrative: Initial report received from a health care professional on 10 November 2011. A 45-year-old male patient received an injection (route and site unknown) of FLUZONE, sanofi pasteur lot number not reported, on 20 October 2011 at 4:30 PM. At 7:30 PM on 20 October 2011, the patient ate shellfish and by 8:00 PM developed watery eyes, shortness of breath, racing heart and felt like his tongue was swollen. The patient treated himself with BENADRYL. On 21 October 2011, the patient was seen at an Urgent Care Center where he was treated with cortisone (one inch 25 gauge) and the symptoms resolved. The patient was seen on 03 November 2011 by a physician. The outcome was reported as recovered. Documents held by sender: None.
Sex: U
Vaccine: FLU3
Symptoms: Cellulitis, Injection site anaesthesia, Oedema peripheral
Clinical narrative: Initial report received from a health care professional on 14 November 2011. The reporter also reported another adverse event, which was captured in case number 2011-11079. An unidentified patient (age and sex not reported) received an intramuscular injection (site not reported) of FLUZONE, sanofi pasteur Inc. lot number UH477AC, on an unknown date. The patient's medical history and concomitant medications were unknown. It was unknown if the patient had any adverse events following prior vaccinations. The patient had no illness at the time of vaccination. On an unknown date, the patient developed numbness on the back of the arm where the injection was given, swelling of the arm and cellulitis. The patient was seen in the Emergency Room (ER) where treatment was given but not specified. The patient had no diagnostic or laboratory testing performed. The outcome was reported as unknown. Documents held by sender: None.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Cellulitis
Clinical narrative: Initial report received from a health care professional on 14 November 2011. This reporter also reported another adverse event, which was captured in case number 2011-09213 and 2011-11124. A 68-year-old female patient received a right arm injection (route not reported) of FLUZONE, sanofi pasteur Inc. lot number UH462AA, on 20 September 2011. The patient's medical history and concomitant medications were not reported. The patient was given the FLUZONE vaccine at the time of discharge from the hospital on 20 September 2011. Two days later on 22 September 2011, the patient presented to the Emergency Department (ED) with cellulitis of the right arm. The patient was treated with intravenous ANCEF and given a prescription for KEFLEX. The patient was re-checked the following day and showed significant improvement. The outcome was reported as recovered. Documents held by sender: None.
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Hypersensitivity, Wheezing
Clinical narrative: Initial report received from a health care professional on 09 November 2011. A female patient received an intradermal injection (site not reported) of FLUZONE Intradermal, sanofi pasteur lot number not reported, on an unknown date. The patient's medical history was not reported. On an unknown date, the patient had a severe allergic reaction with severe wheezing to the FLUZONE intradermal. The patient required treatment with epinephrine and steroids. The outcome was not reported. Documents held by sender: None.
Sex: U
Vaccine: FLU3
Symptoms: Vaccination site cellulitis
Clinical narrative: Initial report received from a health care professional on 14 November 2011. This reporter also reported another adverse event, which was captured in case number 2011-09213 and 2011-11123. An unidentified patient received an injection (route not reported) of FLUZONE, sanofi pasteur Inc. lot number UH453AD, on an unknown date in 2011. The patient's medical history and concomitant medications were not reported. On an unknown date in 2011, the patient developed vaccination site cellulitis. The outcome was not reported. Documents held by sender: None.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Dyspnoea
Clinical narrative: Some shortness of breath and tightness of chest.
Age: 1.72
Sex: M
Vaccine: DTAPIPVHIB, FLU3, HEPA
Symptoms: Blister, Hypersensitivity, Rash erythematous, Rash macular, Rash maculo-papular
Clinical narrative: Pt received 15 m shots (hep a, flu, PENTACEL) on 11/10/2011, then on 11/11 developed rash - erythematous, blotchy, itchy, maculopapular (period) with few vesicles spread all over body - face, neck, perineum, back, chest, thighs, arms, seen by derm -> hypersensitivity reaction.
Age: 1.72
Sex: M
Vaccine: DTAPIPVHIB, FLU3, HEPA
Symptoms: Rash pruritic
Clinical narrative: Pt received 15 m shots (hep a, flu, PENTACEL) on 11/10/2011, then on 11/11 developed rash - erythematous, blotchy, itchy, maculopapular (period) with few vesicles spread all over body - face, neck, perineum, back, chest, thighs, arms, seen by derm -> hypersensitivity reaction.
Age: 37.0
Sex: M
Vaccine: ANTH, TYP
Symptoms: Electromyogram abnormal, Grip strength decreased, Hypoaesthesia, Injection site swelling, Muscular weakness
Clinical narrative: Following receipt of anthrax vaccine #4, which he received with the typhoid vaccine in his right arm, patient recalls experiencing pain and swelling within 4 hours of vaccine receipt. The swelling and pain extended from his shoulder to his wrist. The circumference of his right upper arm increased significantly to the point that his shirtsleeve had to be cut open to relieve the pressure. Patient sought evaluation and was treated with an IM steroid injection and released on a prednisone taper. The pain and swelling lasted about 3 weeks and when the pain resolved, patient experienced persistent numbness and tingling in his right 4th and 5th fingers. This was evaluated by neurology and patient reports significant damage to his ulnar nerve. Patient had an EMG/NCV studies, but results are not visible to the clinic. The patient continues to experience paresthesias of his (R) arm with some accompanying weakness demonstrated by not always being able to grasp things tightly or his grasp giving out. Patient's medical records include an ER note dated 6 April 2000 which noted a subcutaneous nodule over triceps and lists (R) 4th and 5th digit paresthesias. Patient denies angioedema, dyspnea, wheezing, difficulty swallowing or breathing, GI symptoms flu-like symptoms associated with receipt of vaccines. Patient is allergic to morphine --> hives, iodine - -> irritation, and trazodone - - > priapism. He has no food allergies or allergies to insect bites/stings. Patient does not recall anything out of the ordinary with regard to vaccine administration of his 3rd or 4th anthrax vaccine. He denies any trauma or injury to his right upper extremity prior to receipt of anthrax vaccine #4. He has no history of previous vaccine reactions.
Age: 37.0
Sex: M
Vaccine: ANTH, TYP
Symptoms: Nerve conduction studies abnormal, Neuropathy peripheral, Oedema peripheral, Pain in extremity, Paraesthesia
Clinical narrative: Following receipt of anthrax vaccine #4, which he received with the typhoid vaccine in his right arm, patient recalls experiencing pain and swelling within 4 hours of vaccine receipt. The swelling and pain extended from his shoulder to his wrist. The circumference of his right upper arm increased significantly to the point that his shirtsleeve had to be cut open to relieve the pressure. Patient sought evaluation and was treated with an IM steroid injection and released on a prednisone taper. The pain and swelling lasted about 3 weeks and when the pain resolved, patient experienced persistent numbness and tingling in his right 4th and 5th fingers. This was evaluated by neurology and patient reports significant damage to his ulnar nerve. Patient had an EMG/NCV studies, but results are not visible to the clinic. The patient continues to experience paresthesias of his (R) arm with some accompanying weakness demonstrated by not always being able to grasp things tightly or his grasp giving out. Patient's medical records include an ER note dated 6 April 2000 which noted a subcutaneous nodule over triceps and lists (R) 4th and 5th digit paresthesias. Patient denies angioedema, dyspnea, wheezing, difficulty swallowing or breathing, GI symptoms flu-like symptoms associated with receipt of vaccines. Patient is allergic to morphine --> hives, iodine - -> irritation, and trazodone - - > priapism. He has no food allergies or allergies to insect bites/stings. Patient does not recall anything out of the ordinary with regard to vaccine administration of his 3rd or 4th anthrax vaccine. He denies any trauma or injury to his right upper extremity prior to receipt of anthrax vaccine #4. He has no history of previous vaccine reactions.
Age: 37.0
Sex: M
Vaccine: ANTH, TYP
Symptoms: Subcutaneous nodule, Ulnar nerve injury
Clinical narrative: Following receipt of anthrax vaccine #4, which he received with the typhoid vaccine in his right arm, patient recalls experiencing pain and swelling within 4 hours of vaccine receipt. The swelling and pain extended from his shoulder to his wrist. The circumference of his right upper arm increased significantly to the point that his shirtsleeve had to be cut open to relieve the pressure. Patient sought evaluation and was treated with an IM steroid injection and released on a prednisone taper. The pain and swelling lasted about 3 weeks and when the pain resolved, patient experienced persistent numbness and tingling in his right 4th and 5th fingers. This was evaluated by neurology and patient reports significant damage to his ulnar nerve. Patient had an EMG/NCV studies, but results are not visible to the clinic. The patient continues to experience paresthesias of his (R) arm with some accompanying weakness demonstrated by not always being able to grasp things tightly or his grasp giving out. Patient's medical records include an ER note dated 6 April 2000 which noted a subcutaneous nodule over triceps and lists (R) 4th and 5th digit paresthesias. Patient denies angioedema, dyspnea, wheezing, difficulty swallowing or breathing, GI symptoms flu-like symptoms associated with receipt of vaccines. Patient is allergic to morphine --> hives, iodine - -> irritation, and trazodone - - > priapism. He has no food allergies or allergies to insect bites/stings. Patient does not recall anything out of the ordinary with regard to vaccine administration of his 3rd or 4th anthrax vaccine. He denies any trauma or injury to his right upper extremity prior to receipt of anthrax vaccine #4. He has no history of previous vaccine reactions.
Age: 33.0
Sex: F
Vaccine: FLU3, MMR, TDAP, VARCEL
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: (L) arm, back of arm site reaction, redness 66mm, induration 32 mm. Client noticed 11/18/11 at 06:00pm. States reaction reduced the last two days. Referred to MD, client states she will go today.
Age: 29.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Erythema, Injection site warmth, Puncture site induration, Puncture site pain, Rash maculo-papular
Clinical narrative: Presented to employee health services on 11/18/11 with raised erythematous maculopapular area 25 x 40 mm on right arm. Indurated, painful & warm w/central puncture mark. BENADRYL 25 mg tabs given w/directions to take tid-qid prn.
Age: 12.0
Sex: M
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Rash generalised
Clinical narrative: 1 - 1 1/2 hr after vaccines - developed generalized rash. Treated with antihistamines in ER.
Age: 0.83
Sex: M
Vaccine: FLU3
Symptoms: Blood culture, Body temperature increased, Differential white blood cell count, Full blood count, Vomiting
Clinical narrative: Received Flu vaccine 1130AM 9/27/11 and 8 to 9 hours later temp to 104, vomiting and ? febrile seizure, seen in ER & sent home. No residual symptoms.
Age: 50.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site rash
Clinical narrative: Soreness, redness and rash at injection site.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Headache, Lip swelling, Paraesthesia oral
Clinical narrative: 8/19/11 Swollen and tingling lips after 1st injection - did not administer 2nd injection. No Tx or Rx needed after reaction. Also mild headache all symptoms resolved by morning.
Age: 53.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Chest discomfort, Dyspnoea, Eyelid oedema, Ocular hyperaemia
Clinical narrative: SOB bilateral chest discomfort eyes reddened puffy.
Age: 53.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Chest discomfort, Dyspnoea, Eye swelling, Ocular hyperaemia
Clinical narrative: SOB bilateral chest discomfort eyes reddened puffy.
Age: 51.0
Sex: F
Vaccine: FLU3
Symptoms: Rash, Rash erythematous, Skin warm
Clinical narrative: Patient has rash on neck & chest. Rash developed overnight day after shot. Rash is red & hot to touch. "Feels like sunburn" per patient. Took ZYRTEC and small improvement.
Age: 45.0
Sex: F
Vaccine: PPV
Symptoms: Streptococcus test negative, Unevaluable event
Clinical narrative: None stated.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Hypersensitivity, Local reaction
Clinical narrative: Local allergic reaction 4 x 4 cms of raised area on (L) thigh.
Age: 5.0
Sex: M
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site swelling, Pyrexia
Clinical narrative: Fever up to 102 degrees, left deltoid 2+ swelling 1+ erythema.
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Blood test, Chest discomfort, Chest pain, Dyspnoea, Electrocardiogram
Clinical narrative: Information has been received from a 52 year old female with no pertinent medical history and no drug reactions or allergies who on 06-APR-2011 was vaccinated SC with a dose of ZOSTAVAX (Merck) (lot # and dose not reported). There was no concomitant medication. On 19-May-2011, the patient experienced "chest pain, shortness of breath, tightness in her chest" a couple of weeks after having the ZOSTAVAX (Merck). She went to her cardiologist in the Emergency Room and they diagnosed her with pericarditis. The patient was treated with "Pain medication in IV form". "Blood work, electrocardiography (EKG) and x-ray" were performed (results not reported). At the time of the report, the patient was recovering. Follow up information was received from the patient with drug reactions/allergies to BETADINE and no pertinent medical history who in early April 2011 (previously reported as 06-APR-2011) was vaccinated with a dose of ZOSTAVAX (Merck). In "Late April 2011", the patient stated that she developed pericarditis from ZOSTAVAX (Merck). The patient also stated she was hospitalized twice and felt like she was having a heart attack. Patient was treated with MOTRIN for the swelling. Additional information has been requested.
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Feeling abnormal, Pericarditis, Swelling, X-ray
Clinical narrative: Information has been received from a 52 year old female with no pertinent medical history and no drug reactions or allergies who on 06-APR-2011 was vaccinated SC with a dose of ZOSTAVAX (Merck) (lot # and dose not reported). There was no concomitant medication. On 19-May-2011, the patient experienced "chest pain, shortness of breath, tightness in her chest" a couple of weeks after having the ZOSTAVAX (Merck). She went to her cardiologist in the Emergency Room and they diagnosed her with pericarditis. The patient was treated with "Pain medication in IV form". "Blood work, electrocardiography (EKG) and x-ray" were performed (results not reported). At the time of the report, the patient was recovering. Follow up information was received from the patient with drug reactions/allergies to BETADINE and no pertinent medical history who in early April 2011 (previously reported as 06-APR-2011) was vaccinated with a dose of ZOSTAVAX (Merck). In "Late April 2011", the patient stated that she developed pericarditis from ZOSTAVAX (Merck). The patient also stated she was hospitalized twice and felt like she was having a heart attack. Patient was treated with MOTRIN for the swelling. Additional information has been requested.
Age: 70.0
Sex: F
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: Came down with flu symptoms 24 hrs - was sick for 1 week - Flu like symptoms.
Age: 63.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Injection site cellulitis, Pyrexia
Clinical narrative: Initial report received from a health care professional on 23 September 2011. This reporter also reported another adverse event, which was captured in case number 2011-11123 and 2011-11124. This is a non-valid case: Patient identifiers and vaccine lot numbers are missing. This case involves a cluster of unidentified patients with the same reporter, same vaccine (FLUZONE, however lot numbers were unknown) and same event of cellulitis. Three unidentified patients had received a dose of FLUZONE (lot number unknown) on an unspecified date in 2011 and on an unspecified date following vaccination in 2011 they developed cellulitis at the site. The reporter had no additional information to provide at the time of this report, but reported more information would be provided on follow-up. Recovery status for the three patients were not reported. Follow-up information received from a health care professional on 14 November 2011 identified this case as a 63-year-old female patient who received a right arm injection of FLUZONE, sanofi pasteur Inc. lot number UH454AC, on 13 September 2011. The patient had an allergy to sulfa. On 15 September 2011, the patient was seen in the Emergency Department (ED) and diagnosed with cellulitis of the right arm with symptoms of fever and chills. The patient was treated with KEFLEX. The outcome was reported as unknown. Documents held by sender: None.
Age: 7.0
Sex: M
Vaccine: FLU3
Symptoms: Cold sweat, Pallor, Tremor
Clinical narrative: Had 0.5 mL influenza vaccine 11-7-11 at 17:00. Mom states awoke at 0300 et 0600 on 11-8-11 with cold sweats, shakes/tremor, pale. Was improved by 1000 on 11-8-11.
Sex: U
Vaccine: PER
Symptoms: Bordetella test, Pertussis
Clinical narrative: This case is a cluster of 9 unidentified patients' who experienced a similar adverse event following vaccination with pertussis vaccine. Initial report received from a press report on 08 November 2011. The number of cases of whooping cough at an elementary school has reached nine, and now included one teacher. What is unique about these cases is that the affected children had been vaccinated against the illness (vaccine manufacturer, lot, route of administration not reported). The Director of the agency at the school says they are monitoring these nine cases closely, because for every case, they've found another 50 or 60 students who have had close contact with the affected individual. These students were advised to see their doctor for treatment with an antibiotic as a pro-active measure. Potentially affected students were advised to remain in quarantine until the test results were available. If the results are negative, and there are no symptoms, then they can return to school. If a child tests positive, their family members need to go on antibiotics as well. Any child who tests negative for whooping cough, but has a persistent cough, will be treated as a probable case. With the growing number of cases at the school, the county health department still isn't classifying it as an outbreak, but as a cluster because the cases were limited to the eighth grade rather than school-wide. The county health department says there is a 22 percent increase in whooping cough cases throughout the state this year. The outcomes were not reported. Documents held by sender: None.
Age: 93.0
Sex: F
Vaccine: PPV
Symptoms: Inappropriate schedule of drug administration, Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Pt was given second PNEUMOVAX in same calendar year. Developed swelling, pain et baseball/softball size redness at site. Was instructed to apply ice et take ibuprofen. By 11-11-11 improvement to site noted. Voiced no other complaints.
Age: 53.0
Sex: F
Vaccine: FLU3
Symptoms: Back pain, Headache, Neck pain, Paraesthesia, Peripheral nervous system function test normal
Clinical narrative: 10/18/11 8pm - Headache, pain in neck/upper back, tingling on hands & feet. 10/19/11 9am - same symptoms. 10/20/11 12pm - tingling in hands & feet only, pt made appointment with MD (nerve tests done). 10/22/11 3pm - Still tingling, less noticeable, MD office verified. Nerve function OK.
Age: 84.0
Sex: M
Vaccine: FLU3
Symptoms: Asthenia, Dyspnoea, Incontinence, Wheezing
Clinical narrative: Initial report received from a health care professional on 09 November 2011. An 84-year-old male patient received an intramuscular right deltoid injection of FLUZONE, sanofi pasteur Inc. lot number UH477AB, on 27 October 2011. The patient had no known allergies, no illness at the time of vaccination, no other vaccines within 4 weeks of the FLUZONE and denied any adverse events following prior vaccinations. The patient's medical history included increased blood pressure, atrial fibrillation, osteoarthritis and hyperlipidemia. The patient's concomitant medications included albuterol, nitro as needed (prn) COUMADIN, ALDACTONE, K-DUR, ZOCOR, XANAX, SENOKOT and COLACE. On 27 October 2011 hours after the vaccination in the afternoon, the patient complained of feeling very weak and needed help in ambulating, became incontinent, had wheezing and was short of breath. The symptoms lasted a day or so and then completely resolved. The outcome was reported as recovered a day or so later. Documents held by sender: None.
Age: 63.0
Sex: M
Vaccine: FLU3, PPV, FLUX, PPV
Symptoms: Erythema, Oedema peripheral, Pain in extremity, Pyrexia
Clinical narrative: Patient called stating his arm is red, swollen & very painful. He took some rx pain reliever with no relief. Told patient to go to clinic for evaluation; where he was refused treatment. Patient drove back home w/a 103 degree fever. His doctor stated there is nothing they can do for him & not to worry.
Age: 63.0
Sex: M
Vaccine: FLU3, PPV, FLUX, PPV
Symptoms: Injection site pain, Myalgia, Pain in extremity
Clinical narrative: Patient called stating his arm is red, swollen & very painful. He took some rx pain reliever with no relief. Told patient to go to clinic for evaluation; where he was refused treatment. Patient drove back home w/a 103 degree fever. His doctor stated there is nothing they can do for him & not to worry.
Age: 4.0
Sex: F
Vaccine: FLUX
Symptoms: Asthenia, Cough, Pyrexia
Clinical narrative: Very high fever (104.7); weakness; cough. Only CHILDREN ADVIL and CHILDREN TYLENOL (every 6h and 4h).
Age: 9.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Per mom 1 hr after immunization noticed a 8 x 5 in swollen area on (L) deltoid, warm, itchy, gave BENADRYL with relief as needed. Seen in office 2 days later with 3x3 swollen slightly raised warm area.
Age: 49.0
Sex: M
Vaccine: FLUX
Symptoms: Herpes zoster
Clinical narrative: Developed shingles 13 days after flu vaccine (TIV/LAIV) #372 receipt. TIN - 380004876, Diagnosis code - V0481, NPI 1831242528.
Age: 58.0
Sex: F
Vaccine: FLU3
Symptoms: Neck pain, Pain in extremity
Clinical narrative: Pt's partner reported that she experienced pain running down her arm towards her wrist shortly after the immunization. She took ibuprofen & laid down. Later (about 2 hrs) she reported pain was worse, extending into neck and planned to seek medical attention.
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: Drug administered at inappropriate site, Pain in extremity
Clinical narrative: Patient received vaccination and left without any symptoms. Two days later, husband called and said patient's arm was sore. I advised her to massage gently. Patient has been out of town and when I called today, husband said arm was still hurting and she had been to the doctor's office to have it checked. Doctor had no explanation - said vaccine may have been given too high on arm.
Age: 84.0
Sex: M
Vaccine: FLU3
Symptoms: Dizziness, Nausea
Clinical narrative: Dizziness, nausea - few hours after receiving vaccine.
Age: 1.0
Sex: M
Vaccine: FLU3, PNC, VARCEL
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: 3.5 x 2 cm (R) thigh erythema with firm palpable area not fluctuant.
Age: 22.0
Sex: M
Vaccine: HEP
Symptoms: Breath sounds abnormal, Dyspnoea, Wheezing
Clinical narrative: Developed wheezing & SOB in PM after receiving 2nd hep B vaccination on this am. Breath sounds tight. Pulse 96 - RR 26, BP 142/96. Taken to ED per wheelchair.
Age: 66.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Headache
Clinical narrative: Sudden onset headache chills lasted 5 hours.
Age: 49.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Chest discomfort, Chest pain, Chills, Dysphonia, Headache
Clinical narrative: 2 1/2 hours post vaccine she reported headache lump in throat, chest heaviness & raspy voice. "Stabbing chest pain" shakes & chills thru night.
Age: 49.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Sensation of foreign body, Tremor
Clinical narrative: 2 1/2 hours post vaccine she reported headache lump in throat, chest heaviness & raspy voice. "Stabbing chest pain" shakes & chills thru night.
Age: 22.0
Sex: M
Vaccine: FLU3
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Rt handed, c/o numbness & tingling to (R) arm, rcdd fax 10/23/11, day 5 shoulder was numb, feels like to move I have it the worse it becomes. (-) obtained exam 11/2/11. No tx. B/P 100/58. Smoker - 2 packs/week.
Age: 26.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Chest pain, Chills, Cough, Dyspnoea, Ocular hyperaemia
Clinical narrative: Sudden onset eyes reddened & blurred vision - fever & chills, coughing - pain in chest. SOB.
Age: 26.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Pyrexia, Vision blurred
Clinical narrative: Sudden onset eyes reddened & blurred vision - fever & chills, coughing - pain in chest. SOB.
Age: 9.0
Sex: F
Vaccine: FLU3, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: 11/7/11 received varicella immunization at 9:00 AM - 11/8/11 at 800 AM the injection site was 1/2 cm red, slightly warm to touch, no fever. Ice pack given. 11/9/11 8:15AM. 3 1/2 inch (9cm) warm/tender to touch erythematous area at site of injection was seen by NP, ice pack & 200mg ibuprofen given. Return to clinic if worsens, or in AM for recheck.
Age: 0.17
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC, RV5
Symptoms: Allergic colitis, Condition aggravated
Clinical narrative: Rotavirus #1 given to patient w/ GERD and allergic colitis causing flare of colitis, symptoms persisted for months.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Tachycardia
Clinical narrative: 4 hours after receiving vaccine client experienced tachycardia while at rest for 5 minutes. Client was fine for 12-13 hours and then tachycardia returned in AM on 11-10-11.
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: Approx 10 hrs after IM in left arm developed hives on entire body. Not allergic to latex. Took BENADRYL & hives resolved in 2 days.
Age: 1.28
Sex: F
Vaccine: DTAP, MMR, VARCEL
Symptoms: Pyrexia, Rash, Rash erythematous, Rash macular, Vaccination site reaction
Clinical narrative: Large, red blotch at site of varicella vaccination. Scattered blotches, on same leg -& on (R) leg very slight redness at site of MMR on (R) leg. Resolved. Then on 11/9 dev. small  red spots on face with low-grade fever. Presumably due to MMR - disc with parent at the hosp.
Age: 63.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Cough, Dyspnoea, Flushing, Ocular hyperaemia, Oropharyngeal pain
Clinical narrative: Sudden onset SOB, flushed - eyes reddened, cough & sore throat. 148/84 pulse 86 T 98.8.
Age: 46.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Injection site pruritus, Swelling
Clinical narrative: Swelling in right axillary, supraclavicular area. Some itching at site of injection.
Age: 69.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site inflammation
Clinical narrative: Red, inflamed deltoid at location of injection.
Age: 11.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Urticaria
Clinical narrative: Hives all over body; itchy. No SOB/facial swelling/difficulty swallowing.
Age: 1.04
Sex: F
Vaccine: FLU3, MMR, PNC13, VARCEL
Symptoms: Injection site urticaria, Urticaria
Clinical narrative: Diffuse urticaria on arms & legs, within 12 hours of vaccine.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Oedema, Pain, Pain in extremity, Swelling
Clinical narrative: Local soreness started at 11:00 am on 11-09-11. Took 2 ADVIL in afternoon & 2 ADVIL before bed. Did not sleep on arm, but arm sore in morning & took 2 ADVIL. Mammogram technician noticed redness & swelling and edema at 2:15 pm 11-10-11 & advised to see doctor. There was red and  no itching. Doctor said severe reaction rx for prednisone (20mg 2 x day) day & nite antihistamine. 4 ADVIL 2x day & ice.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Vaccination complication
Clinical narrative: Local soreness started at 11:00 am on 11-09-11. Took 2 ADVIL in afternoon & 2 ADVIL before bed. Did not sleep on arm, but arm sore in morning & took 2 ADVIL. Mammogram technician noticed redness & swelling and edema at 2:15 pm 11-10-11 & advised to see doctor. There was red and  no itching. Doctor said severe reaction rx for prednisone (20mg 2 x day) day & nite antihistamine. 4 ADVIL 2x day & ice.
Age: 68.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Joint effusion, Oedema peripheral, Pain in extremity, Paraesthesia
Clinical narrative: Pain, redness, swelling, arm fevered. Fluid collected around elbow. Swelling in the hands - not severe, meds - BENADRYL, TYLENOL, Prednisone (6 day regime) still have some dull tingling in fingers, left hand. Not present before injection. No N&V.
Age: 68.0
Sex: F
Vaccine: PPV
Symptoms: Pyrexia
Clinical narrative: Pain, redness, swelling, arm fevered. Fluid collected around elbow. Swelling in the hands - not severe, meds - BENADRYL, TYLENOL, Prednisone (6 day regime) still have some dull tingling in fingers, left hand. Not present before injection. No N&V.
Age: 72.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Oedema peripheral, Pain, Pyrexia, Rash
Clinical narrative: Fever & pain x 2 days. Right arm swollen to elbow. Large area of rash.
Age: 5.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Electroencephalogram, Tic
Clinical narrative: Facial tic after MMR & VZV.
Age: 8.0
Sex: M
Vaccine: FLU3
Symptoms: Erythema, Oedema peripheral
Clinical narrative: Large local redness, swelling, incorporating shoulder and upper arm.
Age: 78.0
Sex: F
Vaccine: FLUX
Symptoms: Dizziness, Malaise
Clinical narrative: Dizziness - as of 11/13/11 still ill.
Age: 24.0
Sex: M
Vaccine: FLUX
Symptoms: Fatigue, Headache, Nausea
Clinical narrative: Headaches Fatigue nauseated second dose this year around Nov 8th I had a flu shot and the military administered again because I did not have the paper work on hand never had an adverse reaction before except the first shot I ever had.
Age: 65.0
Sex: M
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: Hives.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Depression
Clinical narrative: Parent states that since the patient was adminstered the Gardasil vaccines she has been dx with Chemical Depression. I am not sure about the date above.
Age: 3.0
Sex: M
Vaccine: FLU3, MMR
Symptoms: Convulsion, Dyspnoea, Hypersensitivity, Urticaria
Clinical narrative: Child began showing symptoms currently being considered as seizures. That night he broke out in hives with difficulty breathing. The "allergic reaction" type symptoms persisted 4 days despite treatment with prednisone. The "seizures" are ongoing as of this report. Child will be having EEG and neuro consult.
Age: 67.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Erythema, Fatigue, Inflammation, Pain, Pyrexia
Clinical narrative: Extremely tired and sleepy, feverish, sore, red swollen, inflamed.
Age: 67.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Somnolence, Swelling
Clinical narrative: Extremely tired and sleepy, feverish, sore, red swollen, inflamed.